Literature DB >> 1440218

Growth of a giant aneurysm following complete thrombosis by detachable balloon occlusion.

T Hirasawa1, T Tsubokawa, Y Katayama, Y Koike, Y Ueno, T Hirayama, K Himi.   

Abstract

A giant basilar artery aneurysm demonstrating growth and causing neurological deterioration even after complete detachable balloon occlusion is reported. Autopsy revealed total thrombosis of the aneurysm and a hemiconcentric, onion skin-like, laminated structure. Numerous vascular channels and multiple fresh intramural hemorrhages were noted within the outer margin of the aneurysmal wall. Repeated intramural hemorrhages appeared to have been responsible for the aneurysmal laminated structure and contributed to progressive aneurysmal growth. This case demonstrates that the growth of some giant aneurysms is not dependent upon the continuity with the parent artery, and progressive enlargement cannot always be prevented by balloon occlusion.

Entities:  

Mesh:

Year:  1992        PMID: 1440218     DOI: 10.1016/0090-3019(92)90042-l

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  3 in total

1.  Delayed stroke secondary to increasing mass effect after endovascular treatment of a giant aneurysm by parent vessel occlusion.

Authors:  R Blanc; A Weill; M Piotin; I B Ross; J Moret
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

2.  Parent artery occlusion is not obsolete in giant aneurysms of the ICA. Experience with very-long-term follow-up.

Authors:  Frédéric Clarençon; Fabrice Bonneville; Anne-Laure Boch; Lise Lejean; Alessandra Biondi
Journal:  Neuroradiology       Date:  2010-12-09       Impact factor: 2.804

3.  Predictors of thrombotic complications and mass effect exacerbation after pipeline embolization: The significance of adenosine diphosphate inhibition, fluoroscopy time, and aneurysm size.

Authors:  Radoslav Raychev; Satoshi Tateshima; Fernando Vinuela; Jim Sayre; Reza Jahan; Nestor Gonzalez; Viktor Szeder; Gary Duckwiler
Journal:  Interv Neuroradiol       Date:  2015-11-03       Impact factor: 1.610

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.